Jeffrey Scott Riley, CEO, Director at Theriva Biologics, holds 30.00K shares in Gain Therapeutics (Ticker: GANX), holds 10.40K shares in Theriva Biologics (Ticker: TOVX). Most recently, Jeffrey Scott Riley Bought ― shares of Gain Therapeutics on Apr 01, 2024 for an estimated value of 115.50K.